What Researchers Did
Researchers conducted a prospective randomized trial to investigate the efficacy of extracorporeal shockwave therapy (ESWT) combined with standard care versus standard care alone for chronic diabetic foot ulcers (DFUs).
What They Found
They found that transcutaneous oxygen tension significantly increased in the ESWT group compared to standard care alone at 3 weeks (p=0.044). While ulcer area reduction was 34.5% in the ESWT group versus 5.6% in the control group at 7 weeks, this difference was not statistically significant (p=0.387). However, within the ESWT group, a significant reduction in ulcer area was observed (p<0.01).
What This Means for Canadian Patients
ESWT might offer some benefit in improving tissue oxygenation and reducing ulcer size, but its overall effectiveness for healing diabetic foot ulcers requires more robust evidence. Patients should discuss all treatment options with their healthcare providers, as ESWT is not yet a proven standalone or superior treatment.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
Key limitations include the small sample size (23 patients) and the lack of statistically significant improvement in ulcer healing between the ESWT and control groups.